Merck, Endocyte to Study Vintafolide, Companion Imaging Agent in Multiple Folate-expressing Cancers
April 18, 2012
Merck, Endocyte to Study Vintafolide, Companion Imaging Agent in Multiple Folate-expressing Cancers
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- MDx/CDx Focus: CardioDx's Corus CAD in Heart Study; EMA Filing for Vintafolide; Transrenal KRAS Test
November 28, 2012 / Pharmacogenomics Reporter - After FDA Letter Seeking More Data, Lilly Won't Pursue CDx-Guided Erbitux in NSCLC in the US
May 2, 2012 / Pharmacogenomics Reporter - Roche Receives FDA Nod for New PGx Indication for Tarceva in Metastatic NSCLC with Companion Dx
May 15, 2013 / Pharmacogenomics Reporter - PGx Drugs Xalkori, Zelboraf Show Strong Growth in First Quarter of 2013
May 1, 2013 / Pharmacogenomics Reporter - Pharmas and Dx Partners Race to Launch the First Personalized EGFR Inhibitor for Lung Cancer
January 16, 2013 / Pharmacogenomics Reporter